TY  - GEN
AU  - Fulchiero,E
AU  - Jimeno,A
TI  - Nivolumab
SN  - 1699-3993
PY  - 2017///1205
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Clinical Trials as Topic
KW  - Humans
KW  - Melanoma
KW  - drug therapy
KW  - Neoplasms
KW  - Nivolumab
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1358/dot.2014.50.12.2235103
ER  -